109 related articles for article (PubMed ID: 3346105)
1. Aminoterminal propeptide of type-III procollagen in serum--an indicator of clinical behavior of advanced ovarian carcinoma?
Risteli L; Kauppila A; Mäkilä UM; Risteli J
Int J Cancer; 1988 Mar; 41(3):409-14. PubMed ID: 3346105
[TBL] [Abstract][Full Text] [Related]
2. Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum.
Puistola U; Risteli L; Risteli J; Kauppila A
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1276-81. PubMed ID: 2220941
[TBL] [Abstract][Full Text] [Related]
3. Aminoterminal propeptide of type III procollagen in ovarian cancer. A review.
Risteli L; Risteli J; Puistola U; Tomás C; Zhu GG; Kauppila A
Acta Obstet Gynecol Scand Suppl; 1992; 155():99-103. PubMed ID: 1502898
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous evaluation of epithelial cell function by CA 125 and stromal cell activity by aminoterminal propeptide of type III procollagen (PIIINP) in ovarian carcinoma.
Tomás C; Penttinen J; Risteli J; Risteli L; Kauppila A
Ann Med; 1990 Apr; 22(2):115-21. PubMed ID: 2361007
[TBL] [Abstract][Full Text] [Related]
5. Discrepant expression of carboxy- and aminoterminal propeptides of type I procollagen predicts poor clinical outcome in epithelial ovarian cancer.
Simojoki M; Santala M; Risteli J; Kauppila A
Gynecol Oncol; 2003 Mar; 88(3):358-62. PubMed ID: 12648587
[TBL] [Abstract][Full Text] [Related]
6. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.
Santala M; Simojoki M; Risteli J; Risteli L; Kauppila A
Clin Cancer Res; 1999 Dec; 5(12):4091-6. PubMed ID: 10632345
[TBL] [Abstract][Full Text] [Related]
7. Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity.
Zhu GG; Risteli J; Puistola U; Kauppila A; Risteli L
Cancer Res; 1993 Oct; 53(20):5028-32. PubMed ID: 8402695
[TBL] [Abstract][Full Text] [Related]
8. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
[TBL] [Abstract][Full Text] [Related]
9. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
[TBL] [Abstract][Full Text] [Related]
10. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal propeptide of type III procollagen: a new prognosis indicator in human ovarian cancer.
Kauppila A; Puistola U; Risteli J; Risteli L
Cancer Res; 1989 Apr; 49(7):1885-9. PubMed ID: 2924328
[TBL] [Abstract][Full Text] [Related]
13. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man.
Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J
Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of serum aminoterminal propeptide of type III procollagen as tumor marker in gynecologic malignancies.
Abdel Aziz MT; Abdel Aziz Wassef M; Kamel M; el Zein M; el Hassan H
Tumori; 1993 Jun; 79(3):219-23. PubMed ID: 8236508
[TBL] [Abstract][Full Text] [Related]
15. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.
Hakala A; Kacinski BM; Stanley ER; Kohorn EI; Puistola U; Risteli J; Risteli L; Tomás C; Kauppila A
Am J Obstet Gynecol; 1995 Jul; 173(1):112-9. PubMed ID: 7631667
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy.
von Moers A; Danne T; Möller P; Scheffner D
Acta Paediatr; 1997 Apr; 86(4):377-80. PubMed ID: 9174223
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinoma.
Tomás C; Penttinen J; Risteli J; Risteli L; Vuori J; Kauppila A
Cancer; 1990 Dec; 66(11):2399-406. PubMed ID: 2245396
[TBL] [Abstract][Full Text] [Related]
18. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
[TBL] [Abstract][Full Text] [Related]
19. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
Hørslev-Petersen K; Kim KY; Pedersen LR; Bentsen KD; Uldbjerg N; Oxlund H; Garbarsch C; Hahn EG; Schuppan D; Lorenzen I
APMIS; 1988 Sep; 96(9):793-804. PubMed ID: 3048338
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Clin Chim Acta; 1982 Sep; 124(1):39-44. PubMed ID: 7127838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
